| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human DCN1, defective in cullin neddylation 1, domain containing 1 (S. cerevisiae) (DCUN1D1) from ORIGENE TECHNOLOGIES | TP720243 | 10 ug | ORIGENE TECHNOLOGIES |
| Human DCN1, defective in cullin neddylation 1, domain containing 2 (S. cerevisiae) (DCUN1D2) from ORIGENE TECHNOLOGIES | TP308865 | 20 ug | ORIGENE TECHNOLOGIES |
| Human DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae) (DCUN1D3) from ORIGENE TECHNOLOGIES | TP308082 | 20 ug | ORIGENE TECHNOLOGIES |
| Human DCN1, defective in cullin neddylation 1, domain containing 5 (S. cerevisiae) (DCUN1D5) from ORIGENE TECHNOLOGIES | TP300870 | 20 ug | ORIGENE TECHNOLOGIES |
| Human DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae) (DCUN1D4), transcript variant 2 from ORIGENE TECHNOLOGIES | TP308821 | 20 ug | ORIGENE TECHNOLOGIES |
| Human DCN1, defective in cullin neddylation 1, domain containing 1 (S. cerevisiae) (DCUN1D1) from ORIGENE TECHNOLOGIES | TP303427 | 20 ug | ORIGENE TECHNOLOGIES |
| Human DCP1 decapping enzyme homolog A (S. cerevisiae) (DCP1A) from ORIGENE TECHNOLOGIES | TP301330 | 20 ug | ORIGENE TECHNOLOGIES |
| Human DCP1 decapping enzyme homolog B (S. cerevisiae) (DCP1B) from ORIGENE TECHNOLOGIES | TP307398 | 20 ug | ORIGENE TECHNOLOGIES |
| DIDO1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN413228 | 1 kit | ORIGENE TECHNOLOGIES |
| Dido1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504579 | 1 kit | ORIGENE TECHNOLOGIES |
| Rat Fractalkine ELISA Kit from ORIGENE TECHNOLOGIES | EA100233 | 8x12 divisible strip | ORIGENE TECHNOLOGIES |
| Human follistatin (FST), transcript variant FST344 from ORIGENE TECHNOLOGIES | TP302523 | 20 ug | ORIGENE TECHNOLOGIES |
| Human follistatin (FST), transcript variant FST317. from ORIGENE TECHNOLOGIES | TP723115 | 20 ug | ORIGENE TECHNOLOGIES |
| Human follistatin (FST), transcript variant FST317 from ORIGENE TECHNOLOGIES | TP315777 | 20 ug | ORIGENE TECHNOLOGIES |
| Human follistatin-like 1 (FSTL1) from ORIGENE TECHNOLOGIES | TP300586 | 20 ug | ORIGENE TECHNOLOGIES |
| Human follistatin-like 4 (FSTL4) from ORIGENE TECHNOLOGIES | TP319694 | 20 ug | ORIGENE TECHNOLOGIES |
| Human follistatin-like 1 (FSTL1) from ORIGENE TECHNOLOGIES | TP720885 | 10 ug | ORIGENE TECHNOLOGIES |
| Human follistatin-like 1 (FSTL1) from ORIGENE TECHNOLOGIES | TP721119 | 10 ug | ORIGENE TECHNOLOGIES |
| Human follistatin-like 1 (FSTL1) from ORIGENE TECHNOLOGIES | TP721135 | 10 ug | ORIGENE TECHNOLOGIES |
| Human follistatin-like 3 (secreted glycoprotein) (FSTL3) from ORIGENE TECHNOLOGIES | TP300811 | 20 ug | ORIGENE TECHNOLOGIES |
| SSB - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN405013 | 1 kit | ORIGENE TECHNOLOGIES |
| Ssb - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516755 | 1 kit | ORIGENE TECHNOLOGIES |
| SSB Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH305013 | 10 ug | ORIGENE TECHNOLOGIES |
| Calpain 6 (CAPN6) from ORIGENE TECHNOLOGIES | LY415376 | 100 ug | ORIGENE TECHNOLOGIES |
| Calpain 7 (CAPN7) from ORIGENE TECHNOLOGIES | LY402305 | 100 ug | ORIGENE TECHNOLOGIES |
| Calpain 8 (CAPN8) from ORIGENE TECHNOLOGIES | LY428425 | 100 ug | ORIGENE TECHNOLOGIES |
| Calpain 10 (CAPN10), transcript variant 1 from ORIGENE TECHNOLOGIES | LY411513 | 100 ug | ORIGENE TECHNOLOGIES |
| Calpain 9 (CAPN9), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401979 | 100 ug | ORIGENE TECHNOLOGIES |
| Calpain 9 (CAPN9), transcript variant 2 from ORIGENE TECHNOLOGIES | LY413959 | 100 ug | ORIGENE TECHNOLOGIES |
| CRLF3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN404326 | 1 kit | ORIGENE TECHNOLOGIES |
| CRLF1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN408303 | 1 kit | ORIGENE TECHNOLOGIES |
| Crlf1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN503838 | 1 kit | ORIGENE TECHNOLOGIES |
| CRLF2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN421190 | 1 kit | ORIGENE TECHNOLOGIES |
| Crlf2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN503839 | 1 kit | ORIGENE TECHNOLOGIES |
| Crlf3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN503840 | 1 kit | ORIGENE TECHNOLOGIES |
| CRLF2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH321190 | 10 ug | ORIGENE TECHNOLOGIES |
| CRLF3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH304326 | 10 ug | ORIGENE TECHNOLOGIES |
| C1RL - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN414158 | 1 kit | ORIGENE TECHNOLOGIES |
| CR1L - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN417373 | 1 kit | ORIGENE TECHNOLOGIES |
| C1rl - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502360 | 1 kit | ORIGENE TECHNOLOGIES |
| Cr1l - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN503792 | 1 kit | ORIGENE TECHNOLOGIES |
| CRLS1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN413826 | 1 kit | ORIGENE TECHNOLOGIES |
| CR2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH321379 | 10 ug | ORIGENE TECHNOLOGIES |
| Crls1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN503841 | 1 kit | ORIGENE TECHNOLOGIES |
| Collagen, type VI, alpha 1 (COL6A1) from ORIGENE TECHNOLOGIES | LY419706 | 100 ug | ORIGENE TECHNOLOGIES |
| Collagen, type VI, alpha 2 (COL6A2), transcript variant 2C2a from ORIGENE TECHNOLOGIES | LY409244 | 100 ug | ORIGENE TECHNOLOGIES |
| Collagen, type VI, alpha 2 (COL6A2), transcript variant 2C2 from ORIGENE TECHNOLOGIES | LY419707 | 100 ug | ORIGENE TECHNOLOGIES |
| Collagen, type VII, alpha 1 (COL7A1) from ORIGENE TECHNOLOGIES | LY424928 | 100 ug | ORIGENE TECHNOLOGIES |
| Collagen, type VIII, alpha 2 (COL8A2) from ORIGENE TECHNOLOGIES | LY401592 | 100 ug | ORIGENE TECHNOLOGIES |
| Human Breast, right; Carcinoma in situ of breast, ductal from ORIGENE TECHNOLOGIES | CS804570 | 5x5um | ORIGENE TECHNOLOGIES |